Literature DB >> 23179984

The effect of posterior spinal fusion on respiratory function in Duchenne muscular dystrophy.

W M Alexander1, M Smith, B J C Freeman, L M Sutherland, J D Kennedy, P J Cundy.   

Abstract

PURPOSE: Posterior instrumented spinal fusion is indicated for progressive scoliosis that develops in Duchenne muscular dystrophy (DMD) patients. Whilst spinal fusion is known to improve quality of life, there is inconsistency amongst the literature regarding its specific effect on respiratory function. Our objective was to determine the effect of scoliosis correction by posterior spinal fusion on respiratory function in a large cohort of patients with DMD. Patients with DMD undergoing posterior spinal fusion were compared to patients with DMD not undergoing surgical intervention.
METHODS: An observational study of 65 patients with DMD associated scoliosis, born between 1961 and 2001: 28 of which underwent correction of scoliosis via posterior spinal fusion (Surgical Group) and 37 of which did not undergo surgical intervention (Non-Surgical Group). Pulmonary function was assessed using traditional spirometry. Comparisons were made between groups at set times, and by way of rates of change over time.
RESULTS: There was no correlation between the level of respiratory dysfunction and the severity of scoliosis (as measured by Cobb angle) for the whole cohort. The Surgical Group had significantly worse respiratory function at a comparable age pre-operatively compared to the Non-Surgical Group, as measured by per cent predicted forced vital capacity (p = 0.02) on spirometry. The rate of decline of forced vital capacity and per cent predicted forced vital capacity was not slowed following surgery compared to the non-operated cases. There was no significant difference in survival between the two groups.
CONCLUSIONS: Severity of scoliosis was not a key determinant of respiratory dysfunction. Posterior spinal fusion did not reduce the rate of respiratory function decline. These two points suggest that intrinsic respiratory muscle weakness is the main determinant of decline in respiratory function in DMD.

Entities:  

Mesh:

Year:  2012        PMID: 23179984      PMCID: PMC3555614          DOI: 10.1007/s00586-012-2585-4

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  31 in total

1.  Spinal fusion in patients with Duchenne's muscular dystrophy and a low forced vital capacity.

Authors:  A Marsh; G Edge; J Lehovsky
Journal:  Eur Spine J       Date:  2003-05-14       Impact factor: 3.134

2.  Spinal stabilisation in Duchenne muscular dystrophy.

Authors:  C S Galasko; C Delaney; P Morris
Journal:  J Bone Joint Surg Br       Date:  1992-03

Review 3.  Update on the management of Duchenne muscular dystrophy.

Authors:  A Y Manzur; M Kinali; F Muntoni
Journal:  Arch Dis Child       Date:  2008-07-30       Impact factor: 3.791

4.  Spinal fusion in Duchenne muscular dystrophy.

Authors:  F Miller; C F Moseley; J Koreska
Journal:  Dev Med Child Neurol       Date:  1992-09       Impact factor: 5.449

5.  Treatment and complications in flaccid neuromuscular scoliosis (Duchenne muscular dystrophy and spinal muscular atrophy) with posterior-only pedicle screw instrumentation.

Authors:  Hitesh N Modi; Seung-Woo Suh; Jae-Young Hong; Jae-Woo Cho; Jong-Hoon Park; Jae-Hyuk Yang
Journal:  Eur Spine J       Date:  2009-11-03       Impact factor: 3.134

6.  Managing Duchenne muscular dystrophy--the additive effect of spinal surgery and home nocturnal ventilation in improving survival.

Authors:  Michelle Eagle; John Bourke; Robert Bullock; Mike Gibson; Jwalant Mehta; Dave Giddings; Volker Straub; Kate Bushby
Journal:  Neuromuscul Disord       Date:  2007-05-08       Impact factor: 4.296

7.  Obstructive apnoeas in Duchenne muscular dystrophy.

Authors:  Y Khan; J Z Heckmatt
Journal:  Thorax       Date:  1994-02       Impact factor: 9.139

Review 8.  Chronic respiratory failure and neuromuscular disease.

Authors:  J Declan Kennedy; A James Martin
Journal:  Pediatr Clin North Am       Date:  2009-02       Impact factor: 3.278

9.  Progression of scoliosis in Duchenne muscular dystrophy.

Authors:  A D Smith; J Koreska; C F Moseley
Journal:  J Bone Joint Surg Am       Date:  1989-08       Impact factor: 5.284

10.  Longitudinal study of spinal deformity in Duchenne muscular dystrophy.

Authors:  T Oda; N Shimizu; K Yonenobu; K Ono; T Nabeshima; S Kyoh
Journal:  J Pediatr Orthop       Date:  1993 Jul-Aug       Impact factor: 2.324

View more
  9 in total

Review 1.  Clinical management of Duchenne muscular dystrophy: the state of the art.

Authors:  Sonia Messina; Gian Luca Vita
Journal:  Neurol Sci       Date:  2018-09-14       Impact factor: 3.307

2.  No difference in postoperative complication rates or cardiopulmonary function for early versus late scoliosis correction in Duchenne muscular dystrophy.

Authors:  Ali Asma; Armagan Can Ulusaloglu; Michael Wade Shrader; William G Mackenzie; Robert Heinle; Mena Scavina; Jason J Howard
Journal:  Spine Deform       Date:  2022-06-13

Review 3.  Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management.

Authors:  David J Birnkrant; Katharine Bushby; Carla M Bann; Benjamin A Alman; Susan D Apkon; Angela Blackwell; Laura E Case; Linda Cripe; Stasia Hadjiyannakis; Aaron K Olson; Daniel W Sheehan; Julie Bolen; David R Weber; Leanne M Ward
Journal:  Lancet Neurol       Date:  2018-02-03       Impact factor: 44.182

4.  Safety and Efficacy of Treatment for Scolios Is Secondary to Spinal Muscular Atrophy Fused to Lumbar 5 Level.

Authors:  Shoichiro Takei; Masayuki Miyagi; Wataru Saito; Takayuki Imura; Gen Inoue; Toshiyuki Nakazawa; Eiki Shirasawa; Kentaro Uchida; Tsutomu Akazawa; Naonobu Takahira; Masashi Takaso
Journal:  Spine Surg Relat Res       Date:  2018-04-27

Review 5.  Surgery for scoliosis in Duchenne muscular dystrophy.

Authors:  Daniel K L Cheuk; Virginia Wong; Elizabeth Wraige; Peter Baxter; Ashley Cole
Journal:  Cochrane Database Syst Rev       Date:  2015-10-01

6.  The lifetime risk of pneumonia in patients with neuromuscular scoliosis at a mean age of 21 years: the role of spinal deformity surgery.

Authors:  Heli Keskinen; Heikki Lukkarinen; Katariina Korhonen; Tuomas Jalanko; Antti Koivusalo; Ilkka Helenius
Journal:  J Child Orthop       Date:  2015-09-08       Impact factor: 1.548

7.  Early NIV is associated with accelerated lung function decline in Duchenne muscular dystrophy treated with glucocorticosteroids.

Authors:  Megan E Angliss; Kiara D Sclip; Leanne Gauld
Journal:  BMJ Open Respir Res       Date:  2020-02

8.  Short-term effect and effect on rate of lung function decline after surgery for neuromuscular or syndromic scoliosis.

Authors:  Esther S Veldhoen; Anneloes de Vries; Tom P C Schlosser; Moyo C Kruyt; Ruben P A van Eijk; Joyce M Tersmette; Erik H Hulzebos; Ludo W van der Pol; Roelie M Wösten-van Asperen; Cornelis K van der Ent
Journal:  Pediatr Pulmonol       Date:  2022-02-24

Review 9.  Assessment and management of respiratory function in patients with Duchenne muscular dystrophy: current and emerging options.

Authors:  Antonella LoMauro; Maria Grazia D'Angelo; Andrea Aliverti
Journal:  Ther Clin Risk Manag       Date:  2015-09-28       Impact factor: 2.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.